Carbamic acid, N-[(1S)-1-[[[2S)-2-[5-[4-[5-[2-[(2S)-1-[(2S)-2-[(methoxycarbonyl)amino]-3-methyl-1-oxobutyl]-2-pyrrolidinyl]-1H-imidazol-5-yl]-2-benzofuranyl]phenyl]-1H-imidazol-2-yl]-1-pyrrolidinyl]carbonyl]-2-methylpropyl]-, methyl ester, with CAS number 1246470-32-5, is a complex organic compound characterized by its intricate molecular structure, which includes multiple chiral centers and functional groups. This substance features a carbamic acid moiety, indicating its potential as an amide derivative, and includes various aromatic and heterocyclic components, such as imidazole and benzofuran rings. The presence of a methoxycarbonyl group suggests it may exhibit ester-like properties, contributing to its solubility and reactivity. The compound's stereochemistry is significant, as it may influence biological activity and interactions with enzymes or receptors. Overall, this compound's complexity suggests potential applications in medicinal chemistry, particularly in the development of pharmaceuticals targeting specific biological pathways.

Carbamic acid, N-[(1S)-1-[[(2S)-2-[5-[4-[5-[2-[(2S)-1-[(2S)-2-[(methoxycarbonyl)amino]-3-methyl-1-oxobutyl]-2-pyrrolidinyl]-1H-imidazol-5-yl]-2-benzofuranyl]phenyl]-1H-imidazol-2-yl]-1-pyrrolidinyl]carbonyl]-2-methylpropyl]-, methyl ester

1246470-32-5: Carbamic acid, N-[(1S)-1-[[[2S)-2-[5-[4-[5-[2-[(2S)-1-[(2S)-2-[(methoxycarbonyl)amino]-3-methyl-1-oxobutyl]-2-pyrrolidinyl]-1H-imidazol-5-yl]-2-benzofuranyl]phenyl]-1H-imidazol-2-yl]-1-pyrrolidinyl]carbonyl]-2-methylpropyl]-, methyl ester, with CAS number 1246470-32-5, is a complex organic compound characterized by its intricate molecular structure, which includes multiple chiral centers and functional groups. This substance features a carbamic acid moiety, indicating its potential as an amide derivative, and includes various aromatic and heterocyclic components, such as imidazole and benzofuran rings. The presence of a methoxycarbonyl group suggests it may exhibit ester-like properties, contributing to its solubility and reactivity. The compound's stereochemistry is significant, as it may influence biological activity and interactions with enzymes or receptors. Overall, this compound's complexity suggests potential applications in medicinal chemistry, particularly in the development of pharmaceuticals targeting specific biological pathways.

MK-4882 is an effective inhibitor of HCV NS5A.

CAS 1246470-32-5

Carbamic acid, N-[(1S)-1-[[(2S)-2-[5-[4-[5-[2-[(2S)-1-[(2S)-2-[(methoxycarbonyl)amino]-3-methyl-1-oxobutyl]-2-pyrrolidinyl]-1H-imidazol-5-yl]-2-benzofuranyl]phenyl]-1H-imidazol-2-yl]-1-pyrrolidinyl]carbonyl]-2-methylpropyl]-, methyl ester

MK-4882

Ref: TM-T24475